Technical analysis of Translational Development Acquisition Corp. (TDAC): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Price Performance
| 1 month | +0.18% |
| 3 months | +1.12% |
| Year-to-date | +3.62% |
| 1 year | +5.13% |
52-Week Range
| 52-week High | $10.95 |
| 52-week Low | $10.34 |
| Avg Volume (90d) | 90K |
Technical Indicators
| SMA 50 | $10.82 |
| SMA 200 | $10.64 |
| Beta | -0.01 |
| 30-day Volatility (annualised) | 2.2% |
| Price vs SMA 50 | +0.5% |
| Price vs SMA 200 | +2.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $10.45 | |
| 2025-11 | $10.41 | -0.4% |
| 2025-12 | $10.49 | +0.8% |
| 2026-01 | $10.53 | +0.4% |
| 2026-02 | $10.55 | +0.2% |
| 2026-03 | $10.58 | +0.3% |
| 2026-04 | $10.63 | +0.5% |
| 2026-05 | $10.75 | +1.1% |
| 2026-06 | $10.69 | -0.6% |
| 2026-07 | $10.83 | +1.3% |
| 2026-08 | $10.85 | +0.2% |
| 2026-09 | $10.87 | +0.2% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $10.87 |
| Market Cap | $268M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 42.22 |
| Price / Book | 1.23 |
| EV / EBITDA | -203.40 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 0.06 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 16.43 |